Detalles de la búsqueda
1.
Evaluation and optimization of the syndromic management of female genital tract infections in Nairobi, Kenya.
BMC Infect Dis
; 23(1): 547, 2023 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37608250
2.
Prevalence and Factors Associated with Contraceptive Use Among Kenyan Women Aged 15-49 Years.
AIDS Behav
; 22(Suppl 1): 125-130, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29943124
3.
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
J Infect Dis
; 215(1): 95-104, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28077588
4.
Using a multimethod approach to develop implementation strategies for a cervical self-sampling program in Kenya.
BMC Health Serv Res
; 17(1): 222, 2017 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28320374
5.
Assessment of hepatitis B vaccination status and hepatitis B surface antibody titres among health care workers in selected public health hospitals in Kenya.
PLOS Glob Public Health
; 3(4): e0001741, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37043440
6.
Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda.
Vaccine
; 41(50): 7573-7580, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37981473
7.
Inadequacies in service delivery for the diagnosis and treatment of vaginitis and vaginosis in Nairobi, Kenya.
Int J STD AIDS
; 33(6): 584-596, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380482
8.
Attitudes Toward Gender-Based Violence Among Sexually Active Adult Men at High Risk for HIV in Rustenburg, South Africa.
Am J Mens Health
; 16(3): 15579883221106331, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35748400
9.
Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.
Afr J Lab Med
; 10(1): 1056, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33833946
10.
Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.
PLoS One
; 15(8): e0238028, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32834018
11.
Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care.
PLoS One
; 14(6): e0218369, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31246963
12.
Acceptance of Treatment of Sexually Transmitted Infections for Stable Sexual Partners by Female Sex Workers in Kampala, Uganda.
PLoS One
; 11(5): e0155383, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27171270
13.
Assessment of Anti-HIV-1 Antibodies in Oral and Nasal Compartments of Volunteers From 3 Different Populations.
J Acquir Immune Defic Syndr
; 73(2): 130-7, 2016 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27243901
14.
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.
PLoS One
; 10(5): e0125954, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25961283
15.
Acceptability and feasibility of repeated mucosal specimen collection in clinical trial participants in Kenya.
PLoS One
; 9(10): e110228, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25360819
16.
Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in Africa.
Hum Vaccin Immunother
; 10(3): 714-23, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24374365
17.
Reasons for ineligibility in phase 1 and 2A HIV vaccine clinical trials at Kenya AIDS vaccine initiative (KAVI), Kenya.
PLoS One
; 6(1): e14580, 2011 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21283743
18.
Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa.
PLoS One
; 5(9): e12873, 2010 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-20877623
19.
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity.
Vaccine
; 25(11): 2120-7, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17250931
Resultados
1 -
19
de 19
1
Próxima >
>>